Here are relevant reports on : live-streaming-market
-
IPTV Market by Component (Hardware, Software, Services), Streaming Type, Subscription Type, Transmission Type (Wired, Wireless), Device Type, Application, End User, Vertical, and Region (2022 - 2026)
The IPTV market size is projected to reach 115.2 USD billion in 2026, at a Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period. Major IPTV vendors include AT&T (US), Verizon Communications (US), Ericsson (Sweden), Akamai Technologies (US), Broadcom Corporation (US), Airtel (India), Deutsche Telekom (Germany), Tripleplay Services (India), MatrixStream Technologies (US), CISCO (US), Huawei (China), Sterlite Technologies (India), Exterity(India), Centurylink (US), Orange S.A (France), Setplex (US), Vytio IPTV Solutions (US), Netup (Russia), Foxtel (Australia), Commscope (US), Teledata (Germany), IQStream IPTV(US), Telebreeze (US), Solid IPTV(Australia), LeezTV (Turkey), Broadpeak TV (France), Aigutech Technologies(India), IPTVPORTAL (Russia). These market players have adopted various growth strategies, such as partnerships, collaborations, and new product launches, to expand have been the most adopted strategies by major players from 2019 to 2021, which helped companies innovate their offerings and broaden their customer base.
- Published: October 2021
- Price: $ 4950
- TOC Available:
-
Data Integration Market by Software (Data Integration Platforms, iPaaS, Streaming Integration Tools), Data Type (Structured, Unstructured, Semi-structured), Application (Data Warehousing & BI, Data Lakes & Big Data Management) - Global Forecast to 2030
The data integration market is projected to grow from USD 17.58 billion in 2025 to USD 33.24 billion by 2030, at a CAGR of 13.6% during the forecast period. The major players in the data integration market include IBM (US), SAP (Germany), Oracle (US), Microsoft (US), Google (US), SAS Institute (US), AWS (US), Salesforce (US), Informatica (US), Precisely (US), Tibco (US), Qlik (US), Boomi (US), Fivetran (US), Palantir Technologies (US), Workato (US), Alteryx (US), Huawei (China), Talend (US), Confluent (US), Denodo (US), Snaplogic (US), Jitterbit (US), Actian (US), Celigo (US), DCKAP (US), Safe Software (Canada), Matillion (UK), K2view (Israel), Nexla (US), Exalate (Belgium), Integrately (India), Lonti (Australia), Devart (US), Tray.io (US), Hevo Data (US), Semarchy (France), CData Software (US), Dremio (US), Striim (US), Prophecy (US), Zigiwave (Bulgaria), Adeptia (US), Zapier (US), Frends (Finland), and AB Initio Software (US).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
IoT Device Management Market by Solution (Real-Time Streaming Analysis, Security Solutions, Data Management, Remote Monitoring, Network Bandwidth Management), Service, Application Area, Deployment Model, and Organization Size - Global Forecast to 2022
The IoT device management market size is expected to grow from USD 693.4 Million in 2017 to USD 2,559.6 Million by 2022, at a CAGR of 29.8% from 2017 to 2022. The growing penetration of heterogeneous smart devices and IoT sensors, mandates the critical need for reliable IoT device management platforms or solutions for device remote activation and provisioning, configuration and control, and its management. Converged device management platform offers a single platform to manage devices across multitude of domains and protocols for communication. IoT devices include heterogeneous stand-alone internet connected devices that need to be monitored and controlled from a remote location.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at US$4.39 billion in 2025, stood at US$4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of US$6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral)- Global Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
